Mepsevii

vestronidase alfa · Ultragenyx Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Mepsevii, covering 2017-11-15 to 2026-07-08. Get the full timeline:

Most recent: EMA Authorised: Mepsevii (vestronidase alfa) — Ultragenyx Germany GmbH